GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Y

Youngy Health Co 300247.SZ · CNY

Consumer Discretionary · Shenzhen · 🇨🇳 China

Compare

3.37

-0.59%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥933.2m

FY2016FY2025

Net income

CN¥74.8m

FY2016FY2025

Free cash flow

CN¥105.8m

FY2016FY2025

Shareholders' equity

CN¥1.14bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥933.2mCN¥688.8mCN¥529.4mCN¥463.3mCN¥526.5mCN¥514.1mCN¥730.2mCN¥1.06bnCN¥1.22bnCN¥599.9m
Gross profitCN¥337.4mCN¥216.0mCN¥166.4mCN¥108.7mCN¥118.2mCN¥132.0mCN¥68.1mCN¥225.2mCN¥351.3mCN¥225.9m
Research and developmentCN¥12.3mCN¥11.7mCN¥9.1mCN¥11.0mCN¥13.5mCN¥13.4mCN¥35.2mCN¥63.7mCN¥52.2mCN¥30.5m
Operating incomeCN¥144.3mCN¥88.1mCN¥59.4mCN¥137.2mCN¥38.3m−CN¥47.9m−CN¥724.7m−CN¥776.0mCN¥90.8mCN¥87.5m
Net incomeCN¥74.8mCN¥46.9mCN¥26.6mCN¥126.3mCN¥24.2m−CN¥65.7m−CN¥716.1m−CN¥782.2mCN¥67.7mCN¥85.6m
Diluted earnings per share0.090.070.020.170.03-0.08-0.89-1.050.110.12

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥1.52bnCN¥1.30bnCN¥1.22bnCN¥1.19bnCN¥1.02bnCN¥956.6mCN¥1.13bnCN¥2.02bnCN¥2.97bnCN¥2.79bn
Cash and short-term investments—CN¥570.8mCN¥616.8mCN¥409.3mCN¥283.7mCN¥226.6mCN¥91.1mCN¥179.6mCN¥321.6mCN¥358.8m
Total liabilitiesCN¥268.6mCN¥161.4mCN¥148.9mCN¥158.0mCN¥161.1mCN¥125.3mCN¥244.0mCN¥417.4mCN¥615.8mCN¥517.7m
Debt—CN¥5.4mCN¥17.3mCN¥27.4mCN¥33.5mCN¥7.6mCN¥35.8mCN¥145.5mCN¥205.8mCN¥177.1m
Shareholders' equityCN¥1.14bnCN¥1.07bnCN¥1.02bnCN¥989.0mCN¥831.4mCN¥808.3mCN¥876.2mCN¥1.59bnCN¥2.34bnCN¥2.25bn
Shares outstanding805m711m1,129m745m813m876m803m745m596m689m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥115.7mCN¥51.1mCN¥88.4m−CN¥29.2mCN¥10.8mCN¥81.0mCN¥100.1mCN¥5.6m−CN¥86.4mCN¥43.9m
Capital spending−CN¥9.9m−CN¥8.9m−CN¥7.9m−CN¥17.5m−CN¥6.2m−CN¥8.7m−CN¥23.1m−CN¥28.9m−CN¥49.2m−CN¥19.5m
Free cash flowCN¥105.8mCN¥42.2mCN¥80.5m−CN¥46.7mCN¥4.6mCN¥72.3mCN¥76.9m−CN¥23.4m−CN¥135.5mCN¥24.5m
Dividends paid———−CN¥1,430—−CN¥890,303−CN¥4.0m−CN¥35.8m−CN¥32.9m−CN¥29.9m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥155.5mCN¥239.9mCN¥281.3mCN¥219.1mCN¥181.2mCN¥251.6mCN¥213.0mCN¥142.4m
Gross profitCN¥94.0mCN¥85.4mCN¥97.8mCN¥84.5mCN¥69.5mCN¥85.6mCN¥69.3mCN¥40.0m
Operating incomeCN¥34.5mCN¥47.3mCN¥36.2mCN¥36.9mCN¥26.3mCN¥55.8mCN¥22.5mCN¥12.2m
Net incomeCN¥20.5mCN¥23.7mCN¥8.3mCN¥19.0mCN¥16.5mCN¥31.0mCN¥10.4mCN¥7.8m
Diluted earnings per share0.030.030.010.020.020.040.010.01
Cash from operations———−CN¥19.0m−CN¥4.0mCN¥73.0mCN¥35.0m−CN¥18.0m
Capital spending−CN¥2.0m−CN¥7.0m−CN¥4.0m—−CN¥1.0m−CN¥3.0m−CN¥4.0m−CN¥1.0m
Free cash flow————−CN¥5.0mCN¥70.0mCN¥31.0m−CN¥19.0m
Total assetsCN¥1.55bnCN¥1.51bnCN¥1.52bnCN¥1.48bnCN¥1.46bnCN¥1.33bnCN¥1.30bnCN¥1.26bn
Cash and short-term investments———CN¥524.8mCN¥744.5mCN¥619.9mCN¥570.8mCN¥500.2m
Debt———CN¥18.3mCN¥18.4mCN¥2.1mCN¥5.4mCN¥8.3m
Shareholders' equityCN¥1.18bnCN¥1.16bnCN¥1.14bnCN¥1.13bnCN¥1.11bnCN¥1.10bnCN¥1.07bnCN¥1.05bn

Financial ratios

Data as of 21 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin36.2%31.4%31.4%23.5%22.4%25.7%—
Operating margin15.5%12.9%11.7%30.0%7.3%-8.7%—
Net margin8.0%6.8%5.0%27.3%4.6%-12.8%—
Return on equity6.6%4.4%2.6%12.8%2.9%-8.1%—
Return on assets4.9%3.6%2.2%10.6%2.4%-6.9%—
Free cash flow yield—2.1%2.2%-1.1%0.4%2.6%3.6%
Revenue growth35.5%30.1%14.3%-12.0%2.4%-29.6%—
Earnings growth59.7%76.3%-79.0%421.9%-136.8%-90.8%—
Current ratio6.49x6.54x6.58x6.13x3.92x3.94x—
Debt to equity—0.01x0.01x0.01x0.01x0.01x0.03x
Equity ratio75.1%81.8%83.2%83.3%81.3%84.5%—
Interest coverage—89.46x26.04x50.91x68.88x-43.40x-148.80x
R&D as a share of sales1.3%1.7%1.7%2.4%2.6%2.6%—
Buybacks as a share of market value-13.3%37.0%-51.5%8.4%7.2%-9.1%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue26.3%12.7%8.1%
Operating income1.7%—14.9%
Net income-16.0%—6.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin34.1%31.7%29.5%27.6%
Operating margin14.3%16.4%11.5%-11.3%
Net margin7.5%10.5%6.4%-13.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings55.254.3151.120.9155.2-35.7-3.2-3.349.565.8
Price to sales4.43.77.65.77.14.63.12.42.89.4

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 14 Jun 2018.

FY2018FY2017FY2016FY2015FY2014FY2012
Paid in the year0.030.030.0150.010.050.05
  • 2-for-1 split · 29 Apr 2016
  • 2-for-1 split · 11 Aug 2014
  • 3-for-2 split · 6 Jun 2013

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.